Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Camille L. Bedrosian files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Jeff E. Knight - $3.79M of CRNX open-market activity in the last 12 months
- Justin B. Klee - $3.05M of AMLX open-market activity in the last 12 months
- Joshua B. Cohen - $3.04M of AMLX open-market activity in the last 12 months
- Richard Scott Struthers - $1.00M of CRNX open-market activity in the last 12 months
- Gina Mazzariello - $866K of AMLX open-market activity in the last 12 months
- Dana Pizzuti - $808K of CRNX open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Camille L. Bedrosian?
Camille L. Bedrosian is a corporate insider, tracked as Chief Medical Officer of Amylyx Pharmaceuticals, Inc. (AMLX). InsiderAlpha holds 8 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Camille L. Bedrosian submitted recently?
2 primary Form 4 filings in the last 90 days, covering 2 companies.
Has Camille L. Bedrosian been buying or selling stock?
Recorded transactions: 0 open-market purchases and 5 open-market sales ($431K) across all tracked filings.
Where can I see all of Camille L. Bedrosian's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Camille L. Bedrosian and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
